TipRanks
Terra Innovatum Global (NKLR)
NASDAQ:NKLR
US Market
Want to see NKLR full AI Analyst Report?

Terra Innovatum Global (NKLR) AI Stock Analysis

166 Followers

Top Page

NKLR

Terra Innovatum Global

(NASDAQ:NKLR)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - Gpt-5.6Sol)
Rating:45Neutral
Price Target:
$2.00
▼(-66.72% Downside)
Action:Reiterated
Date:10/17/26
The score is primarily weighed down by weak financial performance (pre-revenue, rapidly rising operating losses, persistent cash burn, and deeply negative equity) and bearish technicals (price far below major moving averages with negative MACD). A very low P/E provides some valuation support, but it is less persuasive given the operating and cash-flow profile.
Positive Factors
Board Independence
Maintaining a majority-independent board supports stronger oversight and regulatory compliance as the company develops. This governance action can improve accountability, reduce conflicts of interest, and provide a more credible framework for strategic and financial decisions over the coming quarters.
Negative Factors
Pre-Revenue Operations
A three-year absence of revenue indicates that the business has not yet demonstrated commercial traction or a functioning revenue engine. At the same time, widening operating losses increase the resources required to reach scale, making future profitability dependent on successful commercialization.
Read all positive and negative factors
Positive Factors
Negative Factors
Board Independence
Maintaining a majority-independent board supports stronger oversight and regulatory compliance as the company develops. This governance action can improve accountability, reduce conflicts of interest, and provide a more credible framework for strategic and financial decisions over the coming quarters.
Read all positive factors

Terra Innovatum Global (NKLR) vs. SPDR S&P 500 ETF (SPY)

Terra Innovatum Global Business Overview & Revenue Model

Company Description
Terra Innovatum Global N.V., a nuclear energy technology company, develops micro-modular nuclear reactors to deliver power solutions. The company offers SOLO, a micro-modular nuclear reactor which generates 1 megawatt electric of baseload power th...

Terra Innovatum Global Earnings Call Summary

Earnings Call Date:Apr 01, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Nov 23, 2026
Earnings Call Sentiment Positive
The call presented meaningful technical and commercial progress: established regulatory engagement with the NRC, secured a qualified supply chain, validated a critical graphite reactor component with Mersen, and reported a substantial pre-commercial pipeline and sufficient cash to fund FOAK. Key risks remain around the delayed 10-K filing, the nonbinding nature of MOUs, pending NRC approvals, and the need to scale manufacturing beyond prototype pieces. On balance, the company has de-risked several execution areas and is positioned to move toward FOAK deployment, though near-term milestones and order conversion will be important to validate the opportunity.
Positive Updates
Regulatory Progress and Engagement
Formal NRC licensing engagement began January 2025; ~10 topical reports and a similar number of white papers submitted to date. Management reports progressing through pre-submittal meetings (second-to-last meeting held) with construction permit phase expected to begin between June and September 2026. Company pursuing FOAK under Part 50 with planned alignment to Part 57 for accelerated commercialization.
Negative Updates
10-K Filing Delay and Procedural Nasdaq Notification
Company missed its previously communicated April 15 10-K filing target and is finalizing technical accounting for noncash items across multiple jurisdictions. Management expects to file in the near term but anticipates receiving a standard Nasdaq notification related to timing.
Read all updates
Q4-2025 Updates
Negative
Regulatory Progress and Engagement
Formal NRC licensing engagement began January 2025; ~10 topical reports and a similar number of white papers submitted to date. Management reports progressing through pre-submittal meetings (second-to-last meeting held) with construction permit phase expected to begin between June and September 2026. Company pursuing FOAK under Part 50 with planned alignment to Part 57 for accelerated commercialization.
Read all positive updates
Company Guidance
The call provided specific operational and timing guidance: Terra has roughly 200 units under non‑binding MOUs (about $4.0 billion of pre‑commercial commitments), identified 130 suppliers and narrowed those to ~30 contract partners, and has produced a Mersen graphite prototype (two blocks within tolerance after work begun Oct/Nov 2025) as it readies manufacturing; licensing formally began Jan 2025 with ~10 topical reports and a similar number of white papers submitted, monthly NRC meetings ongoing (second‑last meeting now, final pre‑construction meeting early May) and the construction‑permit phase expected to start in the June–September window; Rock City is the planned FOAK site (6 million sq ft, option for up to 50 reactors / 50 MWe, initial 15‑year term with potential up to 45 years), the company targets FOAK readiness around 2027 with broader commercialization beginning in 2028, estimates $70 million to achieve FOAK, reports >$100 million cash on hand as of 12/31/2025, and highlights product scalability (1–200 MW market, 1 MWe pilot for AI scaling to 100 MWe, and a “SOLO node” concept yielding ~20 MWe from 16 reactors) plus agreements (e.g., Ameresco and a Fortune 100 energy company) to support deployment.

Terra Innovatum Global Financial Statement Overview

Summary
Financial statements indicate a high-risk, pre-revenue profile: zero revenue across 2023–2025, sharply widening operating losses (to about -$33.7M in 2025), worsening operating cash flow (to about -$10.3M in 2025) and consistently negative free cash flow. The balance sheet shows deeply negative shareholders’ equity (about -$93.6M in 2025), pressuring solvency and flexibility. The large 2025 net income gain appears non-operating/non-recurring given zero revenue and large operating losses, so it does not offset underlying operating weakness.
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
14
Very Negative
BreakdownTTMMar 2026Dec 2024Dec 2023
Income Statement
Total Revenue0.000.000.000.00
Gross Profit-8.00K0.000.000.00
EBITDA530.66M540.96M-153.00K-43.70K
Net Income516.97M539.52M-34.00K-4.47K
Balance Sheet
Total Assets98.52M106.14M133.01K11.87K
Cash, Cash Equivalents and Short-Term Investments91.06M102.88M68.93K1.68K
Total Debt384.00K0.00106.78K0.00
Total Liabilities214.01M199.73M165.15K11.88K
Stockholders Equity-115.50M-93.59M-32.14K-4.00
Cash Flow
Free Cash Flow-18.64M-10.40M87.00-12.61K
Operating Cash Flow-18.15M-10.30M92.00-12.61K
Investing Cash Flow-486.00K-108.00K-230.00M0.00
Financing Cash Flow112.26M112.26M111.58K25.00K

Terra Innovatum Global Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.01
Price Trends
50DMA
3.85
Negative
100DMA
4.53
Negative
200DMA
4.91
Negative
Market Momentum
MACD
-0.47
Negative
RSI
29.97
Positive
STOCH
58.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NKLR, the sentiment is Negative. The current price of 6.01 is above the 20-day moving average (MA) of 2.61, above the 50-day MA of 3.85, and above the 200-day MA of 4.91, indicating a bearish trend. The MACD of -0.47 indicates Negative momentum. The RSI at 29.97 is Positive, neither overbought nor oversold. The STOCH value of 58.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NKLR.

Terra Innovatum Global Risk Analysis

Terra Innovatum Global disclosed 69 risk factors in its most recent earnings report. Terra Innovatum Global reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks

Terra Innovatum Global Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$4.21B7.2615.56%0.66%28.77%25.20%
64
Neutral
$5.59B9.7310.78%4.67%16.18%742.80%
64
Neutral
$1.71B5.4818.17%10.14%50.81%107.08%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
$772.25M4.5710.46%―1.93%-35.13%
53
Neutral
$1.50B6.6913.70%11.89%1.69%―
45
Neutral
$245.31M0.47-662.76%――3270.37%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NKLR
Terra Innovatum Global
2.22
-6.18
-73.57%
EDN
Edenor SA
15.63
-17.68
-53.08%
HE
Hawaiian Electric
8.70
-2.92
-25.13%
PAM
Pampa Energia SA
72.65
-13.15
-15.33%
ENIC
Enel Chile SA
4.13
0.44
11.77%
CEPU
Central Puerto SA
10.61
-3.76
-26.17%

Terra Innovatum Global Corporate Events

Executive/Board ChangesRegulatory Filings and Compliance
Terra Innovatum Director Resigns to Maintain Board Independence
Neutral
Oct 8, 2026
On October 2, 2026, Terra Innovatum Global N.V. announced that Cesare Frepoli resigned from its board of directors, effective the same day, while retaining his roles as the company’s Chief Operating Officer and Co-Chief Executive Officer of ...
Business Operations and StrategyExecutive/Board Changes
Terra Innovatum Global Refreshes Board with Independent Directors
Positive
Sep 23, 2026
On September 17, 2026, Terra Innovatum Global N.V. saw three directors—Rex Jackson, Michael Howard and Peter Hastings—step down from its board, with Hastings transitioning into a consulting role to support the company’s ongoing c...
Business Operations and StrategyExecutive/Board Changes
Terra Innovatum Global Appoints Katherine Williams as CFO
Positive
Aug 27, 2026
On August 21, 2026, Terra Innovatum Corp., the U.S. subsidiary of Terra Innovatum Global N.V., entered into an employment agreement appointing Katherine Williams as Chief Financial Officer of the U.S. Subsidiary through the 2028 annual general mee...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 17, 2026